George Memari

Clinical Trials Operations, Novartis Pharmaceuticals Canada Inc.

George is responsible for enhancement and expansion of alliance and partnership with Canadian Institutions, focused on optimising key operational and start-up activities related to Study Agreements, Budgetary Agreements and ICF language Templates. He is involved in a number of Canadian initiatives and working groups (CTO-QuickStart, CATALIS Québec, CCTCC mCTA and FMV) to promote Canadian visibility and streamline start-up activities and timelines. George started his career in clinical research in 2003 at Bayer Inc., followed by Berlex Canada Inc., Schering-Plough and for the past 12 years at Novartis Pharmaceuticals Canada Inc. George has a bachelor degree in physiology and toxicology from the University of Quebec in Montreal (UQAM).